Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03913143
Brief Title: A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) (ILLUMINATE)

First Submitted : February 21, 2019
First Submitted that Met QC Criteria : April 11, 2019
First Posted : April 12, 2019

Last Update Submitted that Met QC Criteria : January 8, 2021
Last Update Posted : January 11, 2021